COMMUNIQUÉS West-GlobeNewswire

Emerald Health Therapeutics reçoit sa première commande de produits de cannabis pour le marché québécois du cannabis récréatif
30/05/2019
VANCOUVER, Colombie-Britannique, 30 mai 2019 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (« Emerald ») (TSXV: EMH; OTCQX: EMHTF) a reçu sa première commande de la part de la Société québécoise du cannabis ( [...]
Rafarma Joins with Glorija Kotnik to New Victories
30/05/2019
RAFARMA PHARMACEUTICALS INC. “OTC:(RAFA)” Ljubljana, Slovenia , May 30, 2019 (GLOBE NEWSWIRE) -- Rafarma (OTC: RAFA), a Wyoming Corporation, has hired internationally acclaimed professional snowboarder Glorija Kotnik as [...]
AB Science will hold a web conference on its outlook for 2019 on June 4 and 5, 2019 from 5.30 pm to 7pm CET
30/05/2019
Paris, May 30 2019, 6pm AB Science will hold a web conference on its outlook for 2019 on June 4 and 5, 2019 from 5.30 pm to 7pm CET AB Science SA (NYSE Euronext - FR0010557264 - AB) is hosting a web conference to [...]
AB Science organise une conférence web sur ses perspectives de l’année 2019, les 4 et 5 juin 2019, de 17h30 à 19h00 (heure de Paris)
30/05/2019
Paris, 30 mai 2019, 18h AB Science organise une conférence web sur ses perspectives de l’année 2019, les 4 et 5 juin 2019, de 17h30 à 19h00 (heure de Paris) AB Science SA (NYSE Euronext - FR0010557264 - AB) annonce l’ [...]
Kiadis Pharma launches a private placement of new shares to raise approximately EUR 25 million
30/05/2019
Not for release, publication or distribution, directly or indirectly, in or into the United States, Australia, Canada, Japan, south africa or Any other jurisdiction in which such release, publication or distribution [...]
Cronos Group Inc. to Present at Piper Jaffray 39th Annual Consumer Marketplace Conference, Jefferies 2019 Healthcare Conference and Stifel 2019 Cross Sector Insight Conference
30/05/2019
TORONTO, May 30, 2019 (GLOBE NEWSWIRE) -- Cronos Group Inc. (“Cronos Group” or the “Company”) (TSX: CRON) (Nasdaq: CRON), an innovative global cannabinoid company, today announced that Mike Gorenstein, Chairman, [...]
Precipio Pathology Sales Performance Metrics Demonstrate Substantial Improvement in Q1-2019
30/05/2019
Three key metrics are leading indicators of continuous revenue growth NEW HAVEN, Conn., May 30, 2019 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. ( NASDAQ: PRPO ), today provides shareholders [...]
On “Grindeks” results in the first three months of 2019
30/05/2019
“Grindeks” reaches 30.2 million euros turnover and 3.37 million euros profit in the first three months of 2019 Today, on 30 May, the JSC “Grindeks” submitted the non-audited consolidated financial statements of the [...]
Emerald Health Therapeutics Receives First Purchase Order to Supply its Cannabis Products to Quebec Recreational Cannabis Market
30/05/2019
VANCOUVER, British Columbia, May 30, 2019 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF) has received its first purchase order from Société Québécoise du Cannabis (SQDC) to [...]
eSight Corp. Announces a new CEO and $10 Million in Funding
30/05/2019
Joining recent CTO and COO hires, eSight’s new executive team has more than 60 years combined experience in scaling large companies in seven countries across the globe TORONTO, May 30, 2019 (GLOBE NEWSWIRE) -- eSight , [...]
OncBioMune Announces Initial In Vitro Proof-of-Concept Data for PGT in a Multi-Drug Resistant Ovarian Cancer Model
30/05/2019
BATON ROUGE, La., May 30, 2019 (GLOBE NEWSWIRE) -- OncBioMune Pharmaceuticals, Inc. (OTCQB:OBMP) ("OncBioMune" or the "Company"), a clinical-stage biopharmaceutical company engaged in the development of a proprietary [...]
UPDATE -- Tempus Announces $200 Million in Series F Financing
30/05/2019
CHICAGO, May 30, 2019 (GLOBE NEWSWIRE) -- Tempus, a leading technology company advancing precision medicine through the collection and analysis of molecular and clinical data, announced today an additional $200M [...]
Aptose Announces Pricing of Public Offering of Common Shares
30/05/2019
SAN DIEGO and TORONTO, May 30, 2019 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ: APTO, TSX: APS), today announced that it priced its previously announced underwritten public offering [...]
Loos, France, RLG Headquarter, May 29th 2019 : ISOVITAL - Radiopharma Logistics Group (RLG) : “High score for Isovital on its 2019 customers satisfaction survey”.
30/05/2019
The customer satisfaction survey realized in March and April 2019 is now completed and Isovital is rated 17,77 out of 20 by its clients, increasing by 0,43 point its 2017 result.”. Philippe Sueur, Isovital President [...]
Loos, France, siège d'Isovital, 29 mai 2019 : ISOVITAL - Radiopharma Logistics Group (RLG) : 17,77 sur 20 pour Isovital lors de l’enquête de satisfaction clients de 2019.
30/05/2019
L’enquête de satisfaction clients réalisée en mars et avril 2019 vient de produire ses résultats, et Isovital obtient la note de 17,77 sur 20, en amélioration de 0,43 point par rapport à l’enquête de satisfaction [...]
Wildflower Launches at Joel Warren’s ‘The Salon Project’ at Saks Fifth Avenue
30/05/2019
VANCOUVER, British Columbia, May 30, 2019 (GLOBE NEWSWIRE) -- via NetworkWire – Wildflower Brands Inc. (CSE: SUN , OTC: WLDFF ) (the “Company”) is pleased to announce a new collaboration with luxury, beauty and wellness [...]
Philips spotlights integrated diagnostics in oncology at ASCO 2019
30/05/2019
May 30, 2019 Philips oncology solutions provide deeper insights for cancer teams to make better informed decisions and deliver more confident paths to treatment Amsterdam, the Netherlands and Chicago, Illinois – Royal [...]
NRC Health and Hackensack Meridian Health Partner for the First Patient Experience Summit
30/05/2019
Health Care Professionals in Patient Experience, Executive Management and Nursing Will Convene to Discuss Humanizing Care and Connecting to Purpose LINCOLN, Neb., May 30, 2019 (GLOBE NEWSWIRE) -- NRC Health , the [...]
Cerner Declares First Quarterly Dividend
30/05/2019
KANSAS CITY, Mo., May 30, 2019 (GLOBE NEWSWIRE) -- Cerner (NASDAQ: CERN) announced its Board of Directors has declared a cash dividend to stockholders of $0.18 per issued and outstanding share. This reflects a $0.03, or [...]

Pages